Adeshwar Meditex Inkomsten in het verleden

Verleden criteriumcontroles 4/6

Adeshwar Meditex is de winst gegroeid met een gemiddeld jaarlijks percentage van 5%, terwijl de Medical Equipment industrie de winst jaarlijks groeide met 17.6%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 8.2% per jaar. Het rendement op eigen vermogen van Adeshwar Meditex is 6.1%, en het heeft een nettomarge van 2.9%.

Belangrijke informatie

5.0%

Groei van de winst

-3.1%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie	23.0%
Inkomstengroei	8.2%
Rendement op eigen vermogen	6.1%
Nettomarge	2.9%
Laatste winstupdate	30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

Opbrengsten en kosten

Hoe Adeshwar Meditex geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

BSE:543309 Opbrengsten, kosten en inkomsten (INR Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven
30 Sep 24	745	22	18
30 Jun 24	772	21	18
31 Mar 24	799	20	18
31 Mar 23	824	21	21
31 Mar 22	648	8	22
31 Dec 21	617	10	26
30 Sep 21	597	20	21
30 Jun 21	628	19	22
31 Mar 21	660	17	24
31 Mar 20	561	21	23
31 Mar 19	529	23	23
31 Mar 18	586	26	19

Kwaliteitswinsten: 543309 heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (2.9%) 543309 } zijn hoger dan vorig jaar (2.5%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: De winst van 543309 is de afgelopen 5 jaar met 5% per jaar gegroeid.

Versnelling van de groei: De winstgroei van 543309 over het afgelopen jaar ( 7.1% ) overtreft het 5-jarig gemiddelde ( 5% per jaar).

Winst versus industrie: De winstgroei 543309 over het afgelopen jaar ( 7.1% ) overtrof de Medical Equipment -sector 8.8%.

Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 6.1% ) van 543309 wordt als laag beschouwd.

Adeshwar Meditex Inkomsten in het verleden

Verleden criteriumcontroles 4/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Adeshwar Meditex Limited to Report Q2, 2025 Results on Nov 13, 2024

Adeshwar Meditex Limited to Report Q4, 2024 Results on May 22, 2024

Adeshwar Meditex Limited to Report Q2, 2024 Results on Nov 03, 2023

Full year 2023 earnings released: EPS: ₹1.44 (vs ₹0.55 in FY 2022)

Adeshwar Meditex Limited to Report Second Half, 2023 Results on May 25, 2023

Full year 2022 earnings released: EPS: ₹0.55 (vs ₹1.59 in FY 2021)

Recent updates

Adeshwar Meditex Limited to Report Q2, 2025 Results on Nov 13, 2024

Investor sentiment improves as stock rises 20%

Investor sentiment deteriorates as stock falls 18%

Less than half of directors are independent

Investor sentiment improves as stock rises 20%

Adeshwar Meditex Limited, Annual General Meeting, Sep 25, 2024

Adeshwar Meditex Limited Announces Resignation of Mr. Nagaraja Rao Abhinandan from the Position of Chief Financial Officer

Investor sentiment improves as stock rises 17%

Adeshwar Meditex Limited to Report Q4, 2024 Results on May 22, 2024

Adeshwar Meditex Limited Announces the Resignation of Shivani Shivshankar Tiwari as Company Secretary and Compliance Officer

Investor sentiment improves as stock rises 25%

New minor risk - Financial data availability

Adeshwar Meditex Limited Announces Resignation of Sucheta Talati as Non-Executive, Non-Independent Director, Chairman of the Stakeholders Relationship Committee and Member of the Nomination & Remuneration Committee

Investor sentiment improves as stock rises 20%

Investor sentiment improves as stock rises 19%

Adeshwar Meditex Limited to Report Q2, 2024 Results on Nov 03, 2023

Less than half of directors are independent

New major risk - Financial position

Adeshwar Meditex Limited, Annual General Meeting, Sep 26, 2023

Investor sentiment improves as stock rises 17%

Investor sentiment deteriorates as stock falls 24%

No independent directors

No independent directors

Full year 2023 earnings released: EPS: ₹1.44 (vs ₹0.55 in FY 2022)

Adeshwar Meditex Limited Approves Change in the Designation of Shailesh Vinayak Rajpure as Director (Executive)

Adeshwar Meditex Limited to Report Second Half, 2023 Results on May 25, 2023

Investor sentiment improves as stock rises 20%

Investor sentiment deteriorates as stock falls 16%

Adeshwar Meditex Limited Announces Demise of Siddharth Mulchand Talati, Managing Director

Less than half of directors are independent

Adeshwar Meditex Limited Announces Resignation of Shailesh Vinayak Rajpure as Director

Adeshwar Meditex Limited Appoints Shailesh Vinayak Rajpure as Additional Director

Less than half of directors are independent

Adeshwar Meditex Limited Announces Resignation of Shreyas Sampatkumar Jajoo Chief Financial Officer

Less than half of directors are independent

Full year 2022 earnings released: EPS: ₹0.55 (vs ₹1.59 in FY 2021)

Adeshwar Meditex Limited, Annual General Meeting, Sep 28, 2022

Adeshwar Meditex Limited, Annual General Meeting, Sep 28, 2022

Less than half of directors are independent

Less than half of directors are independent

Insider recently bought ₹153k worth of stock

Chief Financial Officer recently sold ₹311k worth of stock

Full year 2022 earnings released: EPS: ₹0.55 (vs ₹1.59 in FY 2021)

Now 26% undervalued

Adeshwar Meditex Limited to Report Fiscal Year 2022 Results on May 13, 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹1.59 (vs ₹2.00 in FY 2020)

Opbrengsten en kosten

Inkomsten en omzetgeschiedenis

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Rendement op eigen vermogen

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden